APA (7th ed.) Citation

H, Y., X, M., T, Z., C, W., Z, Y., T, Z., . . . G, Z. (2023). Immunogenicity and Safety of Homologous Booster Doses of CoronaVac COVID-19 Vaccine in Elderly Individuals Aged 60 Years and Older: A Dosing Interval Study - Yunnan Province, China, 2021-2022. China CDC weekly, 5(6), 125. https://doi.org/10.46234/ccdcw2023.023

Chicago Style (17th ed.) Citation

H, Yang, et al. "Immunogenicity and Safety of Homologous Booster Doses of CoronaVac COVID-19 Vaccine in Elderly Individuals Aged 60 Years and Older: A Dosing Interval Study - Yunnan Province, China, 2021-2022." China CDC Weekly 5, no. 6 (2023): 125. https://doi.org/10.46234/ccdcw2023.023.

MLA (9th ed.) Citation

H, Yang, et al. "Immunogenicity and Safety of Homologous Booster Doses of CoronaVac COVID-19 Vaccine in Elderly Individuals Aged 60 Years and Older: A Dosing Interval Study - Yunnan Province, China, 2021-2022." China CDC Weekly, vol. 5, no. 6, 2023, p. 125, https://doi.org/10.46234/ccdcw2023.023.